Recursion Pharmaceuticals, Inc. (RXRX): Weighted Average Diluted Shares
447.45M
Year ended 2025-12-31
+36.6%
3-year compound annual growth
+83.0%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 447.45M | +63.2% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | 274.21M | +31.9% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | 207.85M | +18.4% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | 175.54M | +40.0% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | 125.35M | +475.5% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | 21.78M | +1.0% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | 21.57M | n/a | 2022-03-23, From 2019-01-01 |